RxDoctor Payments Data

Bradley Collett, MD

Radiation Oncology · Pikeville, KYNPI 1386648988

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Daiichi Sankyo Inc. at 28.4% of the total. Reporting peaked in 2024 at $263 and has fallen 65.8% since, to $90 in 2025. That places this record below the midpoint for radiation oncology clinicians in KY, where the typical reported total is $669.

$668in general payments, 2019–2025

Across 41 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$189
  • Novocure Inc.$123
  • Brainlab, Inc.$98
  • Boston Scientific$35
  • Novartis$34
  • Johnson & Johnson$27
  • plus $161 from 8 others

What the payments were for

  • Food & beverage$668100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$668 in reported general payments places this provider in the 45th percentile of 81 radiation oncology providers in Kentucky.

See all radiation oncology providers in Kentucky

Medicare billing

Part B allowed, 2024
$71,946
Medicare patients
70
Services billed
1,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pilocarpine Hcl17$722
Tamsulosin Hcl92$604
Gabapentin26$384
Prednisolone Sodium Phosphate11$378
Lidocaine Hcl ViscousLidocaine Hcl24$341
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$235
Nystatin15$233
Oxycodone Hcl22$191
Alfuzosin Hcl ErAlfuzosin Hcl23$150

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →